Considering the preliminary correlation between HIF1α expression (as per immunohistochemistry) and areas of high rOEF11, this feature might well reflect hypoxic areas, again highly characteristic of glioblastoma and thus aid in the differentiation between WHO grade II/III glioma and WHO grade IV glioblastoma. Here, HIF1A is linked to central nervous system cancer.